SCHEMBL6895058

SCHEMBL6895058

CCCCCCCCCCC(OCCOCCOC)C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.43
FFAR1 O14842 1/20 0.43
MAPT P10636 2/20 0.42
LCK P06239 1/20 0.42
PPARD Q03181 1/20 0.42
ZDHHC20 Q5W0Z9 1/20 0.42
ZDHHC2 Q9UIJ5 1/20 0.42
ACE2 Q9BYF1 1/20 0.40
PLA2G2A P14555 1/20 0.40
ZDHHC7 Q9NXF8 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
HPGD P15428 1/20 0.38
RECQL P46063 1/20 0.38
HSD17B10 Q99714 1/20 0.38
CA2 P00918 1/20 0.38
GRIK1 P39086 1/20 0.37
GRIK2 Q13002 1/20 0.37
THRB P10828 1/20 0.37
HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7652116 1.00 GPR84 (0.43) GPR84FFAR1MAPTLCKPPARD
SCHEMBL7653752 1.00 GPR84 (0.43) GPR84FFAR1MAPTLCKPPARD
SCHEMBL7647487 1.00 GPR84 (0.43) GPR84FFAR1MAPTLCKPPARD
SCHEMBL7651342 1.00 GPR84 (0.43) GPR84FFAR1MAPTLCKPPARD
SCHEMBL7646223 1.00 GPR84 (0.43) GPR84FFAR1MAPTLCKPPARD
SCHEMBL7647162 1.00 GPR84 (0.43) GPR84FFAR1MAPTLCKPPARD
SCHEMBL7649582 0.95 GPR84 (0.47) GPR84FFAR1MAPTLCKPPARD
SCHEMBL7648359 0.95 GPR84 (0.47) GPR84FFAR1MAPTLCKPPARD
SCHEMBL7648200 0.95 GPR84 (0.47) GPR84FFAR1MAPTLCKPPARD
SCHEMBL7652947 0.95 GPR84 (0.47) GPR84FFAR1MAPTLCKPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0910362-B1 OXA ACIDS AND RELATED COMPOUNDS FOR TREATING SKIN CONDITIONS AVON PROD INC (US) 2004-10-27 EP claimed
CN-1110302-C Oxa acids and related compounds for treating skin conditions AVON PROD INC (US) 2003-06-04 CN claimed
US-6534543-B2 Topical compositions with carboxy acid/ester, amide, or thioester/thioacid groups, with one or more of ether, amine, or sulfide groups; for example 3,6-dioxaheptanioic acid; peeling skin, softening hair AVON PRODUCTS, INC. 2003-03-18 US claimed
US-20020040056-A1 Oxa acids and related compounds for treating skin conditions AVON PRODUCTS, INC. 2002-04-04 US claimed
JP-2000511900-A 2000-09-12 JP claimed
US-6069169-A OXA acids and related compounds for treating skin conditions AVON PRODUCTS, INC. (US) 2000-05-30 US claimed
EP-0910362-A4 OXA ACIDS AND RELATED COMPOUNDS FOR TREATING SKIN CONDITIONS AVON PROD INC (US) 1999-12-22 EP claimed
CN-1221342-A Oxo acids and related compounds for the treatment of skin conditions AVON PROD INC (US) 1999-06-30 CN claimed
EP-0910362-A1 OXA ACIDS AND RELATED COMPOUNDS FOR TREATING SKIN CONDITIONS AVON PRODUCTS, INC. (US) 1999-04-28 EP claimed
US-5847003-A Oxa acids and related compounds for treating skin conditions AVON PRODUCTS, INC. (US) 1998-12-08 US claimed
WO-1997046231-A1 OXA ACIDS AND RELATED COMPOUNDS FOR TREATING SKIN CONDITIONS AVON PRODUCTS, INC. (US) 1997-12-11 WO claimed
EP-0910362-B1 OXA ACIDS AND RELATED COMPOUNDS FOR TREATING SKIN CONDITIONS AVON PROD INC (US) 2004-10-27 EP disclosed
CN-1110302-C Oxa acids and related compounds for treating skin conditions AVON PROD INC (US) 2003-06-04 CN disclosed
US-6534543-B2 Topical compositions with carboxy acid/ester, amide, or thioester/thioacid groups, with one or more of ether, amine, or sulfide groups; for example 3,6-dioxaheptanioic acid; peeling skin, softening hair AVON PRODUCTS, INC. 2003-03-18 US disclosed
US-20020040056-A1 Oxa acids and related compounds for treating skin conditions AVON PRODUCTS, INC. 2002-04-04 US disclosed
US-6071962-A IN TOPICAL APPLICATIONS TO TREAT VARIOUS SKIN CONDITIONS ATTRIBUTED TO, ACCOMPANIED BY OR EXACERBATED BY ABNORMAL DESQUAMATION INCLUDING DRY SKIN, ICHTHYOSIS, PALMAR AND PLANTAR HYPERKERATOSES, DANDRUFF, LICHEN SIMPLEX CHRONICUS AVON PRODUCTS, INC. (US) 2000-06-06 US disclosed
US-6069169-A OXA acids and related compounds for treating skin conditions AVON PRODUCTS, INC. (US) 2000-05-30 US disclosed
EP-0910362-A4 OXA ACIDS AND RELATED COMPOUNDS FOR TREATING SKIN CONDITIONS AVON PROD INC (US) 1999-12-22 EP disclosed
CN-1221342-A Oxo acids and related compounds for the treatment of skin conditions AVON PROD INC (US) 1999-06-30 CN disclosed
EP-0910362-A1 OXA ACIDS AND RELATED COMPOUNDS FOR TREATING SKIN CONDITIONS AVON PRODUCTS, INC. (US) 1999-04-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020040056-A1 Oxa acids and related compounds for treating skin conditions OXGR1, OXA1L, CXCR1 GPR84 779/4885FFAR1 310/4885MAPT 4837/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.